scholarly article | Q13442814 |
P50 | author | Steven H Ferris | Q37369822 |
Barry Reisberg | Q42412559 | ||
Mony J de Leon | Q51766178 | ||
P2093 | author name string | Miller JD | |
Wolf AP | |||
Kluger A | |||
George AE | |||
Sachs HJ | |||
P2860 | cites work | Alzheimer's disease: cell-specific pathology isolates the hippocampal formation | Q34261572 |
Hemisphere differences in the acquisition and use of descriptive systems | Q38500632 | ||
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia | Q48305999 | ||
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia | Q48719942 | ||
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose | Q48768629 | ||
Alzheimer's disease and the parietal lobe | Q48773987 | ||
Patterns of declining memory. | Q52261348 | ||
Pathological and positron emission tomographic correlations in Alzheimer's disease. | Q53189657 | ||
The Global Deterioration Scale for assessment of primary degenerative dementia | Q57279034 | ||
Positron Emission Tomography in the Study of Aging and Senile Dementia | Q57279043 | ||
P433 | issue | 2 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 248-251 | |
P577 | publication date | 1987-04-01 | |
P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
P1476 | title | Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. | |
P478 | volume | 7 |
Q48649929 | A high-resolution single photon emission computed tomography study of verbal recognition memory in Alzheimer's disease |
Q48491979 | Brain correlates of memory processes in patients with dementia of Alzheimer's type: a SPECT Activation Study |
Q37645211 | Brain single photon emission computed tomography: newer activation and intervention studies |
Q48958695 | Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function |
Q40896821 | Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives |
Q48607587 | Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease |
Q34149288 | Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging |
Q46067123 | Human brain metabolic responses to familiarity during lexical decision |
Q38459906 | Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study |
Q38461160 | Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type |
Q36942866 | Parallel Distributed Processing and Neural Networks: Origins, Methodology and Cognitive Functions |
Q36443614 | Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease. |
Q48464716 | Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease |
Q53187649 | Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease. |
Q36401418 | Translational research in central nervous system drug discovery |
Q67488364 | Treatment of Alzheimer's disease |
Q48474992 | Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism |
Q41096506 | Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease |
Q48622112 | d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain |
Search more.